Realist Pharma is a private immunotherapy company with facilities in Montreal and Toronto, which has developed a platform technology ("ReVax") to target multiple cancers through an active immune response. More specifically, Realist has developed novel, small molecule, carbohydrate-based therapeutics which generate efficacious anti-tumor